Evolocumab (AMG 145) 是一种抑制PCSK9的人源化单克隆抗体。Evolocumab 与循环的 PCSK9 蛋白结合，抑制其与 LDLR 结合。Evolocumab 可用于高胆固醇血症和动脉粥样硬化性心血管疾病的研究。
| 生物活性 | Evolocumab (AMG 145) is a human monoclonal antibody that inhibitsPCSK9. Evolocumab binds to the circulating PCSK9 protein, inhibiting it from binding to the LDLR. Evolocumab can be used for the research of hypercholesterolemia and atherosclerotic cardiovascular diseases[1]. |
| IC50& Target | |
| Clinical Trial | |
| 性状 | |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com